Showing results (41-50 of 170) with videos related to
Sort By:
Pageof 17
JAMA Psychiatry|January 12, 2018
Efficacy of Transdermal Estradiol and Micronized Progesterone in the Prevention of Depressive Symptoms in the Menopause Transition: A Randomized Clinical TrialJennifer L Gordon, David R Rubinow, Tory A Eisenlohr-Moul, et al.The Journal of Clinical Psychiatry|May 29, 2008
A cross-sectional evaluation of perimenopausal depressionEmma M Steinberg, David R Rubinow, John J Bartko, et al.Biological Psychiatry|June 30, 2007
Risk for premenstrual dysphoric disorder is associated with genetic variation in ESR1, the estrogen receptor alpha geneLiang Huo, Richard E Straub, Catherine Roca, et al.Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|April 21, 2005
Testosterone suppression of CRH-stimulated cortisol in menDavid R Rubinow, Catherine A Roca, Peter J Schmidt, et al.Archives of Women'S Mental Health|August 3, 2019
Transdermal estradiol for postpartum depression: results from a pilot randomized, double-blind, placebo-controlled studyHoward J Li, Pedro E Martinez, Xiaobai Li, et al.Archives of General Psychiatry|October 7, 2004
The effects of pharmacologically induced hypogonadism on mood in healthy menPeter J Schmidt, Kate L Berlin, Merry A Danaceau, et al.The American Journal of Psychiatry|January 31, 2013
Abnormalities of dorsolateral prefrontal function in women with premenstrual dysphoric disorder: a multimodal neuroimaging studyErica B Baller, Shau-Ming Wei, Philip D Kohn, et al.Genes|June 28, 2023
Divergent Transcriptomic Effects of Allopregnanolone in Postpartum DepressionSarah A Rudzinskas, Maria A Mazzu, Crystal Edler Schiller, et al.North Carolina Medical Journal|September 10, 2011
UNC Health Systems and Blue Cross and Blue Shield of North Carolina patient-centered medical home collaborativeDon Bradley, David R RubinowDialogues in Clinical Neuroscience|October 29, 2011
Sex-dependent modulation of treatment responseDavid R Rubinow, Molly MoorePageof 17